Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
7.43
-0.33 (-4.25%)
At close: Apr 1, 2025, 4:00 PM
7.90
+0.47 (6.38%)
After-hours: Apr 1, 2025, 4:12 PM EDT
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $47.50 million as of April 1, 2025. Its market cap has increased by 101.44% in one year.
Market Cap
47.50M
Enterprise Value
-8.75M
1-Year Change
101.44%
Ranking
Category
Stock Price
$7.43
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has decreased from $181.43M to $47.50M, a decrease of -73.82%. That is a compound annual growth rate of -24.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 49.61M | -65.83% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | 467.16M | 157.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |